Phoenix, AZ – Today, Governor Katie Hobbs signed an Executive Order expanding access to COVID vaccines in Arizona. This action seeks to protect the health and safety of Arizona families ahead of respiratory disease season, and to reduce the strain on Arizona’s hospital system and health care workers.Continue reading
Author Archive: AZBio
XLR8 PBC Introduces Fall 2025 Cohort
XLR8 PBC has cemented its role as a unique and highly impactful program within the health tech ecosystem. A strategic launchpad for companies poised for significant growth and market penetration, the program has been designed to support founders/CEOs with access to top industry leaders, mentorship, and strategic resources.
New Arizona’s Bioscience Roadmap: How the state becomes a nationally recognized bioscience hub
The Flinn Foundation releases a new Arizona’s Bioscience Roadmap to guide industry discovery, innovation, and economic growth for the next five years. The new plan builds on Arizona’s talent base, world-class research, and entrepreneurial spirit to improve the economy as well as Arizonans’ health and quality of life. Developed by SRI International of Menlo Park, Calif., the Roadmap launches at stakeholder events statewide and online the week of Sept. 8, 2025.Continue reading
Flinn Foundation Translational Seed Grants Program – Apply by Oct. 31 2025
It’s that time of the year again. The Flinn Foundation is seeking applicants for the 11th cohort of its Translational Seed Grants Program! The RFP opened Sept. 3, 2025 and closes on Friday, Oct. 31.Continue reading
Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering
TUCSON, ARIZONA, August 28, 2025 — Picard Medical, Inc. (“Picard” or the “Company”), a medical technology company that manufactures and sells the only total artificial heart (the “SynCardia Total Artificial Heart”, or “STAH”) approved by the U.S. Food and Drug Administration (“FDA”), and Health Canada, today announced the pricing of its initial public offering (the “Offering”). The Offering consists of 4,250,000 shares of common stock priced at a public offering price of $4.00 per share, for total gross proceeds of $17 million, before deducting underwriting discounts and offering expenses. The shares of common stock have been approved for listing on the NYSE American, LLC and are expected to commence trading on August 29, 2025, under the ticker symbol “PMI.”Continue reading
GPEC Board of Directors names Christine Mackay as President & CEO
Over 11 years with the City of Phoenix, Mackay led the creation of more than $190 billion in capital investment and 100,000 new jobsContinue reading
Arizona Commerce Authority Announces Awardees For Fall 2025 Arizona Innovation Challenge
PHOENIX, AZ (August 27, 2025) – The Arizona Commerce Authority (ACA) today announced 10 awardees have been selected for the Fall 2025 Arizona Innovation Challenge (AIC). The Fall 2025 cohort includes some of the state’s most promising Software as a Service (SaaS)/AI startups.
Discovery could lead to new treatments for life-threatening allergic reactions
ASU researchers probe how the gut responds to severe food allergiesContinue reading
Edson seed grants awarded to explore clues behind neurodegenerative diseases
5 ASU researchers will use the awards as opportunities for high-impact studiesContinue reading